MEDIF Company Profile and Key Details

MediPharm Labs Corp. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 13, 2026, missed forecasts by 0.0%. The prior quarter beat by -41.39%. Over the last six quarters, Apple has recorded several small beats. These include 49.67% in May 15, 2024.

Average 10-day trading volume of 27.44 thousand shares is below the 3-month average of 63.62 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently mid-range between its 52-week high and low $0.04 and $0.08. With a market capitalization of about $22.43 million, MediPharm Labs Corp. is classified as a micro-cap and shows market-like volatility (beta ~0.99). Key stats such as the average daily volume over the past year has been around 66.94 thousand shares, volume is running light vs its 52-week average. Headquartered in Barrie, ON, MediPharm Labs Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Greg Hunter, the company employs approximately 127 people and listed since January 08, 2021. MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products.

Our AI price prediction model suggests that MediPharm Labs Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows MediPharm Labs Corp. trading at a premium to the broader market with a P/E of -6.33.

MediPharm Labs Corp. trades at a P/E ratio of -6.33, slightly below the S&P 500 average, with a price-to-sales ratio of 0.76 and a price-to-book ratio of 0.9 suggesting the stock is closer to book value. The P/FCF stands at -34.38, also below market averages.